BIOPORTO DIAGNOSTICS A/S: Financial statements 2025
CVR: 18645882
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
BIOPORTO DIAGNOSTICS A/S (CVR 18645882) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 40,286,970 and a net result of DKK -81,398,096 compared with DKK -110,908,377 the year before. That is an increase of 11.2% compared with the year before. The profit margin was -202%. Equity in the 2025 report amounted to DKK -837,580,713. The company had 26 employees in the financial year.
- Revenue
- DKK 40,286,970
- Gross Profit
- DKK -18,865,571
- Profit/Loss
- DKK -81,398,096
- Equity
- DKK -837,580,713
- Total Assets
- DKK 24,806,739
- Employees
- 26
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 40.3M | -18.9M | -81.4M | -837.6M | 26 |
| 2024 | 36.2M | -8.3M | -110.9M | -756.2M | 22 |
| 2023 | 31M | -4.4M | -104.8M | -645.3M | 21 |
| 2022 | 29M | -13.2M | -81.8M | -540.5M | 20 |
| 2021 | 24.3M | -15.2M | -54.1M | -458.7M | 15 |
Official annual report
How creditworthy is BIOPORTO DIAGNOSTICS A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of September 1, 2025, Carsten Buhl has joined the board of directors of BIOPORTO DIAGNOSTICS A/S.
As of September 1, 2025, Peter Mørch Eriksen has left the board of directors of BIOPORTO DIAGNOSTICS A/S.
As of September 1, 2025, Carsten Buhl is registered as adm. dir. of BIOPORTO DIAGNOSTICS A/S.
As of September 1, 2025, Peter Mørch Eriksen has stepped down as adm. dir. of BIOPORTO DIAGNOSTICS A/S.
BIOPORTO DIAGNOSTICS A/S has published its annual report for 2024. Revenue came to DKK 36,243,216, and the net result was DKK -110,908,377.
As of February 1, 2025, Niels Jørgen Høy Nielsen has joined the board of directors of BIOPORTO DIAGNOSTICS A/S.
As of February 1, 2025, Nis Glavind Kruse has left the board of directors of BIOPORTO DIAGNOSTICS A/S.
About BIOPORTO DIAGNOSTICS A/S
BIOPORTO DIAGNOSTICS A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 1995. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ANTIBODYSHOP A/S and IMMUNOLEX ApS. The management consists of Carsten Buhl. The board consists of Gry Louise Husby Larsen (chair), Carsten Buhl and Klaus Juhl Wulff. The company is owned by BIOPORTO A/S. The company has 28 employees (2026). In 2025, the company reported revenue of DKK 40,286,970 and a net result of DKK -81,398,096 compared with DKK -110,908,377 the year before. Equity in the 2025 report amounted to DKK -837,580,713.